Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly ...

Shandong Boan Biotechnology Co., Ltd. has received marketing approval from China’s National Medical Products Administration for Boyouping® (Dulaglutide Injection), a biosimilar to Trulicity ...

The 40-week SUSTAIN 7 trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin.

There are seven types of GLP-1 agonists currently available in the US: Dulaglutide, Exenatide, Exenatide extended-release, Liraglutide, Lixisenatide, Semaglutide injection, and Semaglutide tablets.

Results Interviews were completed by 201 participants (52.7% male; mean age = 58.7). Preferences between treatment processes varied widely. Mean utilities were 0.890 for simple oral, 0.880 for oral ...

Topline data were announced from a head-to-head phase 3 trial evaluating tirzepatide vs dulaglutide in adults with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease ...

Once-weekly tirzepatide conferred a similar cardiovascular risk as once-weekly dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease, according to ...

Treating patients who have type 2 diabetes and atherosclerotic cardiovascular disease with tirzepatide (Mounjaro) results in MACE rates similar to those seen with the older diabetes drug dulaglutide ...

Both doses of dulaglutide tested in the phase 2 study met the end point of noninferiority for 24-hour mean systolic blood pressure, but only the 1.5-mg dose was superior to placebo for reducing ...